Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361252246> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4361252246 abstract "<div>Abstract<p>A library of 2′-methoxyethyl-modified antisense oligonucleotides (2′MOE ASO) targeting 1,510 different genes has been developed, validated, and used to identify cell cycle regulatory genes. The most effective molecular target identified was Eg5 (kinesin-like-1), which when inhibited gave the largest increase in 4N DNA in various tumor cells. The Eg5 ASO reduced Eg5 levels, inhibited proliferation, increased apoptosis, and altered the expression of other cell cycle proteins, including survivin and Aurora-A. To examine the therapeutic utility of the Eg5 ASO, the compound was also evaluated in xenograft models. Treatment with Eg5 ASO produced a statistically significant reduction of tumor growth, reduction in Eg5 expression in the tumors, and changes in histone phosphorylation, consistent with a loss of Eg5 protein expression. These data show, for the first time, the utility of a 2′MOE ASO library for high-throughput cell culture–based functional assays and suggest that an Eg5 ASO also has potential in a therapeutic strategy. (Cancer Res 2006; (66)4: 2059-66)</p></div>" @default.
- W4361252246 created "2023-03-31" @default.
- W4361252246 creator A5001459712 @default.
- W4361252246 creator A5009015108 @default.
- W4361252246 creator A5009075790 @default.
- W4361252246 creator A5009399366 @default.
- W4361252246 creator A5027611703 @default.
- W4361252246 creator A5027827928 @default.
- W4361252246 creator A5029066300 @default.
- W4361252246 creator A5035791999 @default.
- W4361252246 creator A5051698673 @default.
- W4361252246 creator A5067505935 @default.
- W4361252246 creator A5069849278 @default.
- W4361252246 creator A5079126152 @default.
- W4361252246 date "2023-03-30" @default.
- W4361252246 modified "2023-09-30" @default.
- W4361252246 title "Data from Use of a Chemically Modified Antisense Oligonucleotide Library to Identify and Validate Eg5 (Kinesin-Like 1) as a Target for Antineoplastic Drug Development" @default.
- W4361252246 doi "https://doi.org/10.1158/0008-5472.c.6495003" @default.
- W4361252246 hasPublicationYear "2023" @default.
- W4361252246 type Work @default.
- W4361252246 citedByCount "0" @default.
- W4361252246 crossrefType "posted-content" @default.
- W4361252246 hasAuthorship W4361252246A5001459712 @default.
- W4361252246 hasAuthorship W4361252246A5009015108 @default.
- W4361252246 hasAuthorship W4361252246A5009075790 @default.
- W4361252246 hasAuthorship W4361252246A5009399366 @default.
- W4361252246 hasAuthorship W4361252246A5027611703 @default.
- W4361252246 hasAuthorship W4361252246A5027827928 @default.
- W4361252246 hasAuthorship W4361252246A5029066300 @default.
- W4361252246 hasAuthorship W4361252246A5035791999 @default.
- W4361252246 hasAuthorship W4361252246A5051698673 @default.
- W4361252246 hasAuthorship W4361252246A5067505935 @default.
- W4361252246 hasAuthorship W4361252246A5069849278 @default.
- W4361252246 hasAuthorship W4361252246A5079126152 @default.
- W4361252246 hasBestOaLocation W43612522462 @default.
- W4361252246 hasConcept C104317684 @default.
- W4361252246 hasConcept C105696609 @default.
- W4361252246 hasConcept C129312508 @default.
- W4361252246 hasConcept C153911025 @default.
- W4361252246 hasConcept C185592680 @default.
- W4361252246 hasConcept C190283241 @default.
- W4361252246 hasConcept C20418707 @default.
- W4361252246 hasConcept C2775975398 @default.
- W4361252246 hasConcept C29537977 @default.
- W4361252246 hasConcept C502942594 @default.
- W4361252246 hasConcept C54355233 @default.
- W4361252246 hasConcept C55493867 @default.
- W4361252246 hasConcept C59006786 @default.
- W4361252246 hasConcept C62112901 @default.
- W4361252246 hasConcept C81885089 @default.
- W4361252246 hasConcept C86803240 @default.
- W4361252246 hasConcept C95444343 @default.
- W4361252246 hasConceptScore W4361252246C104317684 @default.
- W4361252246 hasConceptScore W4361252246C105696609 @default.
- W4361252246 hasConceptScore W4361252246C129312508 @default.
- W4361252246 hasConceptScore W4361252246C153911025 @default.
- W4361252246 hasConceptScore W4361252246C185592680 @default.
- W4361252246 hasConceptScore W4361252246C190283241 @default.
- W4361252246 hasConceptScore W4361252246C20418707 @default.
- W4361252246 hasConceptScore W4361252246C2775975398 @default.
- W4361252246 hasConceptScore W4361252246C29537977 @default.
- W4361252246 hasConceptScore W4361252246C502942594 @default.
- W4361252246 hasConceptScore W4361252246C54355233 @default.
- W4361252246 hasConceptScore W4361252246C55493867 @default.
- W4361252246 hasConceptScore W4361252246C59006786 @default.
- W4361252246 hasConceptScore W4361252246C62112901 @default.
- W4361252246 hasConceptScore W4361252246C81885089 @default.
- W4361252246 hasConceptScore W4361252246C86803240 @default.
- W4361252246 hasConceptScore W4361252246C95444343 @default.
- W4361252246 hasLocation W43612522461 @default.
- W4361252246 hasLocation W43612522462 @default.
- W4361252246 hasOpenAccess W4361252246 @default.
- W4361252246 hasPrimaryLocation W43612522461 @default.
- W4361252246 hasRelatedWork W2016433185 @default.
- W4361252246 hasRelatedWork W2026380718 @default.
- W4361252246 hasRelatedWork W2185175380 @default.
- W4361252246 hasRelatedWork W2350294409 @default.
- W4361252246 hasRelatedWork W2358161411 @default.
- W4361252246 hasRelatedWork W2358789216 @default.
- W4361252246 hasRelatedWork W2362964312 @default.
- W4361252246 hasRelatedWork W2374067319 @default.
- W4361252246 hasRelatedWork W2383691845 @default.
- W4361252246 hasRelatedWork W2605273235 @default.
- W4361252246 isParatext "false" @default.
- W4361252246 isRetracted "false" @default.
- W4361252246 workType "article" @default.